Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies

Over the past years, progress has been made in cancer immunotherapy following the development of immune checkpoint inhibitors (ICI) that have been proved effective in the management of many malignancies. Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte antigen-4 (CTLA-4), has been ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsoli, Marina, Kaltsas, Gregory, Angelousi, Anna, Alexandraki, Krystallenia, Randeva, Harpal, Kassi, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537807/
https://www.ncbi.nlm.nih.gov/pubmed/33061641
http://dx.doi.org/10.2147/CMAR.S224791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537807/
https://www.ncbi.nlm.nih.gov/pubmed/33061641
http://dx.doi.org/10.2147/CMAR.S224791

Ejemplares similares